Small Molecules

20 Jun 2007 Nuvo provides update on discussions with the FDA related to Pennsaid approval
20 Jun 2007 Sativex® receives Qualifying Notice for approval in Canada for the relief of Cancer Pain
20 Jun 2007 DeveloGen and Teva Enter into Exclusive License Agreement for DeveloGen’s Protein Kinase B Technology for the Treatment of Cancer
20 Jun 2007 Surface Logix Commences Phase 2A Clinical Trial of SLx-2101 in Hypertension
20 Jun 2007 Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
20 Jun 2007 Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
19 Jun 2007 Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
19 Jun 2007 Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
19 Jun 2007 Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
19 Jun 2007 Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
19 Jun 2007 NicOx provides an update on NCX 4016
19 Jun 2007 BioCryst presents Phase I Peramivir data at the options for the control of influenza conference
19 Jun 2007 Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
19 Jun 2007 Novelos Therapeutics announces encouraging results in ongoing phase 2 ovarian cancer trial at Dana-Farber/Partners Cancer Care
19 Jun 2007 EPIX Receives FDA Response to Vasovist(TM) Appeal
16 Jun 2007 Collegium Pharmaceutical Inc., Announces the Filing of IND for Abuse Deterrent Sustained Release Opioid Product
16 Jun 2007 FDA Issues Third Approvable Letter for Thelin (Sitaxsentan Sodium)
16 Jun 2007 New positive pre-clinical data for Active Biotech's RA project I-3D
16 Jun 2007 Prexige(R) study shows significantly less impact on blood pressure than ibuprofen in osteoarthritis patients with controlled hypertension
16 Jun 2007 New Research Demonstrates Broad Efficacy of Azixa(TM) (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
16 Jun 2007 Orchid forays into the non-antibiotic generic formulations segment
16 Jun 2007 U.S. Food and Drug Administration Approves Gilead’s Letairis(TM) (ambrisentan) 5 mg and 10 mg Tablets for the Once-Daily Treatment of Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms
15 Jun 2007 Axcan Pharma Initiates MAX-002 Phase III Clinical Trial to Evaluate the Efficacy and Safety of a High-Concentration 1 Gram Mesalamine Suppository
15 Jun 2007 Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
15 Jun 2007 Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up